Trial site
Seoul
- 12running trials
- 9closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Asthma3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Gastric and oesophageal cancer2 trials
- Multiple myeloma2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- Colorectal cancer1 trial
- COPD1 trial
- Haemophilia1 trial
- Liver and biliary tract cancer1 trial
- and 3 more
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting9 trials
- Completed6 trials
- Terminated3 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi20 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Active, not recruiting
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- COPD1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Terminated
Terminated
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026